BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hsu C, Marshall JL, He AR. Workup and Management of Immune-Mediated Hepatobiliary Pancreatic Toxicities That Develop During Immune Checkpoint Inhibitor Treatment. Oncologist. 2020;25:105-111. [PMID: 32043797 DOI: 10.1634/theoncologist.2018-0162] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Pelaez-Luna M, Soriano-Rios A, Lira-Treviño AC, Uscanga-Domínguez L. Steroid-responsive pancreatitides. World J Clin Cases 2020; 8(16): 3411-3430 [PMID: 32913848 DOI: 10.12998/wjcc.v8.i16.3411] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Hirota M, Murakami K, Koiwai A, Kawamura K, Yoshino Y, Takasu A, Kin R, Katayama T, Endo K, Kogure T, Meguro T, Tabata T, Murakami K, Satoh K. Neutrophil Infiltration and Acinar-ductal Metaplasia are the Main Pathological Findings in Pembrolizumab-induced Pancreatitis: A Case Report. Intern Med . [DOI: 10.2169/internalmedicine.9565-22] [Reference Citation Analysis]
3 Zhang Y, Zhang X, Li W, Du Y, Hu W, Zhao J. Biomarkers and risk factors for the early prediction of immune-related adverse events: a review. Hum Vaccin Immunother 2022;:1-12. [PMID: 35108160 DOI: 10.1080/21645515.2021.2018894] [Reference Citation Analysis]
4 Tan B, Chen MJ, Guo Q, Tang H, Li Y, Jia XM, Xu Y, Zhu L, Wang MZ, Qian JM. Clinical-radiological characteristics and intestinal microbiota in patients with pancreatic immune-related adverse events. Thorac Cancer 2021;12:1814-23. [PMID: 33943036 DOI: 10.1111/1759-7714.13990] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Gambichler T, Reuther J, Scheel CH, Becker JC. On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19. J Immunother Cancer 2020;8:e001145. [PMID: 32611687 DOI: 10.1136/jitc-2020-001145] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
6 Macía-Rodríguez C, Santomé Couto L, Fernández Villaverde A, Romero Reinoso C, de la Fuente Aguado J. Mycophenolate mofetil as a treatment of severe steroid-resistant immune-related hepatitis. Gastroenterol Hepatol 2021:S0210-5705(21)00191-6. [PMID: 34118320 DOI: 10.1016/j.gastrohep.2021.05.008] [Reference Citation Analysis]
7 Wakabayashi G, Lee YC, Luh F, Kuo CN, Chang WC, Yen Y. Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway. J Biomed Sci 2019;26:96. [PMID: 31801525 DOI: 10.1186/s12929-019-0588-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
8 Godbert B, Petitpain N, Lopez A, Nisse YE, Gillet P. Hepatitis B reactivation and immune check point inhibitors. Dig Liver Dis 2021;53:452-5. [PMID: 32921602 DOI: 10.1016/j.dld.2020.08.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Lebossé F, Bancel B, Levrero M, Merle P. [Management of immune checkpoint inhibitors-induced liver toxicity in cancer]. Bull Cancer 2020;107:1056-68. [PMID: 32951849 DOI: 10.1016/j.bulcan.2020.06.011] [Reference Citation Analysis]
10 Kerdsirichairat T, Shin EJ. Endoscopic ultrasound guided interventions in the management of pancreatic cancer. World J Gastrointest Endosc 2022; 14(4): 191-204 [DOI: 10.4253/wjge.v14.i4.191] [Reference Citation Analysis]
11 Xie T, Wang N, Yao G, Xu S, Wang D, Liu X, Hu L, Lu G, Shi R, Ding Y. PD-1/PDL1 Blockade Exacerbates Pancreatic Damage and Immune Response in a Mouse Model of Acute Pancreatitis. Inflammation 2021;44:1441-51. [PMID: 33598777 DOI: 10.1007/s10753-021-01430-1] [Reference Citation Analysis]
12 Raschi E, Gatti M, Gelsomino F, Ardizzoni A, Poluzzi E, De Ponti F. Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance. Target Oncol 2020;15:449-66. [PMID: 32725437 DOI: 10.1007/s11523-020-00738-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
13 Costa LB, Queiroz MA, Barbosa FG, Nunes RF, Zaniboni EC, Ruiz MM, Jardim D, Gomes Marin JF, Cerri GG, Buchpiguel CA. Reassessing Patterns of Response to Immunotherapy with PET: From Morphology to Metabolism. Radiographics 2021;41:120-43. [PMID: 33275541 DOI: 10.1148/rg.2021200093] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]